US Broker Ratings

Hologic, Inc. (HOLX) Stock Analysis: Navigating the Healthcare Sector with a 2.72% Potential Upside

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, is steadily making its mark in the medical instruments and supplies industry. With a market capitalization of $16.53 billion,..

AstraZeneca PLC (AZN): Investor Outlook on a $276 Billion Healthcare Giant with Promising 4.55% Upside

AstraZeneca PLC (NYSE: AZN) stands as a towering presence in the healthcare sector, boasting a robust market capitalization of $276.26 billion. Specializing in the development and commercialization of prescription medicines,..

STERIS plc (STE) Stock Analysis: Investor Outlook with an 8.98% Upside Potential

In the ever-evolving healthcare sector, STERIS plc (NYSE: STE) stands out as a robust player in the medical devices industry. Headquartered in Mentor, Ohio, and with a market capitalization of..

Charles River Laboratories (CRL) Stock Analysis: Exploring the 12.59% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a significant player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $8.33 billion,..

Abbott Laboratories (ABT) Stock Analysis: Exploring a 10.63% Upside Potential for Healthcare Investors

Abbott Laboratories (ABT), a prominent player in the healthcare sector, stands out as a giant in the medical devices industry with a market capitalization of $227.08 billion. Founded in 1888..

Globus Medical, Inc. (GMED) Stock Analysis: A Strong Healthcare Contender with a 6.57% Potential Upside

Globus Medical, Inc. (NASDAQ: GMED), a prominent player in the healthcare sector, particularly in medical devices, is capturing the attention of investors with its robust growth metrics and promising future..

Chemed Corp (CHE) Investor Outlook: Exploring a 31.84% Potential Upside

Chemed Corp (NYSE: CHE) operates at the intersection of healthcare and essential services, with its diverse portfolio encompassing hospice and palliative care through its VITAS segment, as well as plumbing..

Exact Sciences Corporation (EXAS) Stock Analysis: Potential 22.48% Upside Ignites Investor Interest

Exact Sciences Corporation (EXAS), a prominent player in the healthcare sector, has captured investor attention with its impressive potential upside and robust product pipeline. Specializing in diagnostics and research, the..

Merck & Co., Inc. (MRK) Stock Analysis: Strong Buy Ratings and 10% Potential Upside

Merck & Co., Inc. (NYSE: MRK), a titan in the healthcare sector, continues to capture investor attention with its robust market position and promising growth trajectory. As one of the..

BioNTech SE (BNTX) Investor Outlook: Analyzing 31.92% Potential Upside Amid Biotech Innovations

BioNTech SE (NASDAQ: BNTX), a pioneering force in the biotechnology sector, has captured investor attention with its innovative approaches to immunotherapy and infectious disease treatment. Headquartered in Mainz, Germany, BioNTech’s..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Investors Eye 12% Upside in Healthcare Giant

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, presents a compelling investment opportunity for those looking to capitalize on..

Viatris Inc. (VTRS) Stock Analysis: Uncovering the 13% Potential Upside Amidst Healthcare Challenges

In the dynamic world of healthcare, Viatris Inc. (VTRS) stands as a compelling entity, navigating a complex landscape with its extensive portfolio of prescription and generic drugs. Headquartered in Canonsburg,..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 19.74% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a leading healthcare company, stands as a formidable player in the healthcare plans industry. With a market capitalization of $301.21 billion, UnitedHealth Group continues to..

BeOne Medicines Ltd. (ONC) Stock Analysis: Robust Growth Potential with 41% Revenue Growth

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, has captured the attention of investors with its impressive growth trajectory and innovative oncology treatments. Based in Switzerland, this..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 9.99% Potential Upside in the Biotech Sector

United Therapeutics Corporation (NASDAQ: UTHR) presents a compelling opportunity for investors interested in the healthcare sector, specifically in the niche of specialty and generic drug manufacturing. With a market capitalization..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 13.28% Upside Potential in the Healthcare Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands as a beacon in the healthcare sector, specializing in the development and manufacturing of medical devices. With a robust market cap of..

Universal Health Services, Inc. (UHS) Stock Analysis: A Look at the Healthcare Giant’s Growth Potential and Market Position

Investors with an interest in the healthcare sector might find Universal Health Services, Inc. (NYSE: UHS) a compelling addition to their portfolios. With a market capitalization of $14.22 billion, UHS..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Marvel with 26% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical innovator, is making waves in the biotechnology sector with its promising growth trajectory and a substantial 26.17% potential upside. As it stands,..

Royalty Pharma plc (RPRX) Stock Analysis: 16% Upside Potential Captures Investor Interest

Royalty Pharma plc (NASDAQ: RPRX) sits at a unique intersection of finance and healthcare, offering investors a distinctive opportunity to engage with the biopharmaceutical sector. With a market capitalization of..

Novartis AG (NVS) Stock Analysis: Strong ROE and Solid Dividend Yield Amidst Market Volatility

Novartis AG (NVS) stands as a formidable player in the global healthcare sector, with a market capitalization of $254.27 billion, making it one of the leading drug manufacturers worldwide. Headquartered..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds